What’s Equity Crowdfunding And Why Does It Matter Now?

The window closes on August 27, and the price is $3.00/share. This is your chance to own the science.

If you’ve ever watched a biotech IPO and thought: “Why didn’t I hear about this earlier?”

Here’s your answer: Because the system was built to exclude you, until now.

Thanks to Regulation A+, companies like Cytonics can now raise capital from everyday investors, not just hedge funds and institutional elites.

This isn’t crypto. This isn’t hype. This is real equity in a clinical-stage biotech, and you can invest right now. 

But not for long. The Cytonics Reg A+ round closes at 11:59 p.m. on August 27. This is the final opportunity to invest at $3.00/share before potential future raises at higher valuations.


What Is Equity Crowdfunding?

It’s a way for private companies to raise money directly from the public; legally, transparently, and with SEC oversight.

Cytonics used it to:

• Reject traditional VC and Wall Street control
• Raise $25M+ from 7,000+ individual investors
• Build a clean, fair cap table with equal-share terms
• Let people like you own shares in a biotech doing clinical-stage science, not just theory

Just 12 Days Left to Join

With the August 27 deadline approaching fast, here’s what you’re getting when you invest now:

• A share of a clinical-stage biotech, post–Phase 1
• Exposure to a $393B osteoarthritis market
• IP protection with 25 issued patents
• The same $3.00/share price as early believers
• A chance to say, “I got in before the next phase.”

The Final Countdown Has Begun

• Invest today, raise closes August 27 at 11:59 p.m.
• Only 12 days left to join at $3.00/share
• Secure your stake in the next generation of joint health
• Join 7,000+ investors before the door shuts

Stand with 7,000+ investors in shaping the future of OA treatment.